GAD and IA2 autoantibody positivity is associated with a requirement for insulin treatment: results of the UK national paediatric Type 2 Diabetes cohort

Zoe Gray; Emma Ilsley; Catherine Cotter; Lydiah Makusha; Anna Ford; Kelly Turner; James Heywood; Kyla Chandler; Polly J. Bingley; Anthony Barnett

doi:10.1530/endoabs.33.p30

GAD and IA2 autoantibody positivity is associated with a requirement for insulin treatment: results of the UK national paediatric Type 2 Diabetes cohort

Identifier:nobleid.org/w1/20260515/D560B7EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D560B7EB.svg?ark=w1%2F20260515%2FD560B7EB)](https://nobleid.org/work/w1/20260515/D560B7EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

GAD and IA2 autoantibody positivity is associated with a requirement for insulin treatment: results of the UK national paediatric Type 2 Diabetes cohort

Identifier:nobleid.org/w1/20260515/D560B7EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D560B7EB.svg?ark=w1%2F20260515%2FD560B7EB)](https://nobleid.org/work/w1/20260515/D560B7EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work